Entacapone for Parkinson’s Disease (Comtess)
Entacapone enhances levodopa effectiveness for Parkinson's patients experiencing wearing-off symptoms between doses.

About entacapone
Entacapone, commonly known by the brand name Comtess, is a medication specifically designed to manage symptoms of Parkinson’s disease in patients already taking levodopa-based treatments. Parkinson’s disease is a progressive neurological disorder characterized by the loss of dopamine-producing cells in the brain, leading to motor symptoms such as tremors, stiffness, and slowed movement. Levodopa, found in medications like co-beneldopa (Madopar®) or co-careldopa (Sinemet®), is converted into dopamine in the brain to alleviate these symptoms. However, over time, many patients experience a ‘wearing-off’ effect, where symptoms return before the next dose due to fluctuating levodopa levels.
Entacapone belongs to a class of drugs called COMT inhibitors (catechol-O-methyltransferase inhibitors). It works by blocking the enzyme COMT, which normally breaks down levodopa in the body before it can reach the brain. By inhibiting this enzyme, entacapone prolongs the effect of each levodopa dose, increasing ‘on’ time (periods of good symptom control) and reducing ‘off’ time (periods of poor control). Clinical studies have shown that entacapone, when added to levodopa/carbidopa therapy, significantly extends daily on-time by about 1-1.5 hours and reduces off-time accordingly, improving motor function scores on the Unified Parkinson’s Disease Rating Scale (UPDRS).
This medication is typically prescribed by a specialist, such as a neurologist, for patients with advanced Parkinson’s who have been on levodopa for several years and are experiencing end-of-dose deterioration. It is not a standalone treatment but an adjunct to enhance existing levodopa therapy. Entacapone is available as 200 mg tablets and is often used in combination formulations like levodopa/carbidopa/entacapone (Stalevo®), approved by the FDA for motor fluctuations.
Before taking entacapone
Before starting entacapone, a thorough medical evaluation is essential to ensure it is safe and appropriate for you.
Allergies and medical history
- Inform your doctor if you are allergic to entacapone, other COMT inhibitors, or any ingredients in Comtess tablets.
- Discuss your full medical history, particularly liver disease, kidney problems, heart conditions (e.g., recent heart attack, arrhythmias), low blood pressure, glaucoma, or a history of psychosis or hallucinations, as these may contraindicate use or require dose adjustments.
- Entacapone is not recommended during pregnancy or breastfeeding due to limited safety data; effective contraception is advised for women of childbearing potential.
Other medicines
Entacapone can interact with several medications, potentially altering their effects or increasing side effects:
- MAO-B inhibitors (e.g., selegiline, rasagiline) or non-selective MAO inhibitors: Risk of severe hypertension; use with caution or avoid.
- Other COMT inhibitors (e.g., tolcapone): Not to be combined.
- Iron supplements or multivitamins: May reduce entacapone absorption; take at least 2-3 hours apart.
- Antihypertensives or diuretics: May enhance blood pressure-lowering effects.
- Psychotropics (e.g., antipsychotics, antidepressants): Increased risk of adverse CNS effects.
- Provide your doctor with a complete list of prescription, over-the-counter, and herbal medicines.
Pregnancy and breastfeeding
Animal studies suggest potential risks to the fetus; human data are insufficient. Consult your doctor for alternatives if planning pregnancy. Entacapone passes into breast milk in small amounts; breastfeeding is not recommended during treatment.
How and when to take entacapone
Entacapone is taken orally as 200 mg tablets, always in conjunction with each dose of co-beneldopa or co-careldopa. Do not take it alone.
Dosage
- Standard dose: 200 mg with every levodopa dose, up to a maximum of 10 tablets (2000 mg) per day.
- Your specialist will adjust based on response and tolerability; do not exceed prescribed amount.
- For combination products like Stalevo, follow specific tablet strengths (e.g., 50/12.5/200 mg levodopa/carbidopa/entacapone).
Administration
- Swallow tablets whole with water; can be taken with or without food, but consistent timing aids absorption.
- If you miss a dose, take it as soon as remembered unless near the next dose; do not double up.
- Tablets may turn urine, sweat, or saliva reddish-brown (harmless).
| Levodopa Dose Time | Entacapone Dose |
|---|---|
| 8 AM | 200 mg |
| 12 PM | 200 mg |
| 5 PM | 200 mg |
| 9 PM | 200 mg |
Side effects of entacapone
Most side effects are mild and related to increased dopamine activity, often improving over time. About 10-20% of patients discontinue due to adverse events.
Common side effects
Affecting more than 1 in 100 people:
- Dyskinesia (involuntary movements): Most common; may require levodopa dose reduction by 10-30%.
- Nausea, vomiting, abdominal pain, diarrhea, constipation.
- Dry mouth, urine discoloration.
- Orthostatic hypotension (dizziness on standing).
- Hallucinations, insomnia, or vivid dreams.
Serious side effects
Seek immediate medical help for:
- Severe allergic reactions (rash, swelling, breathing difficulty).
- Neuroleptic malignant syndrome (high fever, muscle rigidity, confusion) – rare.
- Worsening mental symptoms (agitation, paranoia).
- Uncontrolled dyskinesia or severe hypotension.
Long-term considerations
Regular monitoring for liver function is advised, though entacapone has lower hepatotoxicity risk than tolcapone. No routine blood tests required unless symptoms suggest issues.
How to cope with side effects
- Dyskinesia: Reduce levodopa dose slightly; report to doctor.
- Nausea: Take with food; antiemetics like domperidone if needed (avoid metoclopramide).
- Diarrhea: Stay hydrated; use loperamide short-term.
- Dizziness: Rise slowly; ensure adequate fluid/salt intake.
- Hallucinations: Discuss dose adjustment or add quetiapine.
- Maintain a symptom diary to track patterns and effectiveness.
Precautions while taking entacapone
- Avoid alcohol, as it may worsen dizziness or drowsiness.
- Do not drive or operate machinery until you know how it affects you.
- Wear sunscreen; entacapone may increase sun sensitivity.
- Inform dentists/surgeons before procedures due to interactions with anesthetics.
- Monitor blood pressure regularly, especially if prone to hypotension.
Frequently Asked Questions (FAQs)
Q: Can entacapone be taken without levodopa?
A: No, entacapone must always be used with co-beneldopa or co-careldopa; it enhances levodopa’s effects but has no independent activity.
Q: How long does it take for entacapone to work?
A: Benefits on ‘on’ time are usually noticeable within 2-4 weeks, with peak effects in clinical trials seen over 6 months.
Q: Does entacapone cause liver damage?
A: Rare; unlike tolcapone, entacapone has no significant hepatotoxicity risk, but liver tests may be monitored if symptoms arise.
Q: Can I stop entacapone suddenly?
A: No; abrupt withdrawal may worsen Parkinson’s symptoms. Taper under medical supervision.
Q: Is entacapone suitable for early Parkinson’s?
A: Primarily for advanced stages with wearing-off; not first-line.
Important information
If symptoms worsen, experience severe side effects, or notice signs of allergy/infection, contact your doctor immediately. Store tablets at room temperature, away from moisture. Dispose of unused medication properly. Regular follow-ups with your neurologist are crucial to optimize therapy and manage progression.
References
- Entacapone. A review of its use in Parkinson’s disease — PubMed/Drugs. 1999-08-01. https://pubmed.ncbi.nlm.nih.gov/10439935/
- Levodopa/Carbidopa/Entacapone Combination Therapy — NCBI Bookshelf/StatPearls. 2023-07-17. https://www.ncbi.nlm.nih.gov/books/NBK599508/
- Entacapone: Uses, Interactions, Mechanism of Action — DrugBank Online. 2023. https://go.drugbank.com/drugs/DB00494
- Entacapone: MedlinePlus Drug Information — MedlinePlus/NIH. 2023. https://medlineplus.gov/druginfo/meds/a601236.html
- Entacapone for Parkinson’s disease – Patient.info — Patient.info. 2023. https://patient.info/medicine/entacapone-for-parkinsons-disease-comtess
Read full bio of Sneha Tete
















